Friday, May 10, 2024 8:09:52 PM
I don't normally either. Dipped in 4 times now and came out good each time. The world for the most part is waking up. Those that have the desire to know about
what they swallow or take as an injection are finding out how bad these vaccines are maiming and killing people. 5.7 billion people injected. Cancers going off the charts... new Turbo cancers, and so many other secondary effects. Only the really stupid or those in denial are still hanging on to their "dividends". However, I know all well about hanging on and wishing and hoping. Why not long ago, a stock I held for about a decade came to life again and I got out with a small profit! Pfizer has not yet seen the bottom. So I am looking to short some more on any rallies. They are lucky though. They have the FDA in their pockets and will have many chances to make a come back. This is turning into my favorite love/hate stock.
what they swallow or take as an injection are finding out how bad these vaccines are maiming and killing people. 5.7 billion people injected. Cancers going off the charts... new Turbo cancers, and so many other secondary effects. Only the really stupid or those in denial are still hanging on to their "dividends". However, I know all well about hanging on and wishing and hoping. Why not long ago, a stock I held for about a decade came to life again and I got out with a small profit! Pfizer has not yet seen the bottom. So I am looking to short some more on any rallies. They are lucky though. They have the FDA in their pockets and will have many chances to make a come back. This is turning into my favorite love/hate stock.
Bearish
Recent PFE News
- Bristol Myers Squibb and Pfizer to Make Eliquis® (apixaban) Available via Mark Cuban Cost Plus Drug Company • Business Wire • 04/24/2026 10:59:00 AM
- Pfizer Declares Second-Quarter 2026 Dividend • Business Wire • 04/22/2026 08:45:00 PM
- Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026 • Business Wire • 04/21/2026 03:51:00 PM
- U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility • PR Newswire (US) • 04/20/2026 10:45:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 05:16:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/16/2026 08:31:02 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/10/2026 05:10:35 PM
- Pfizer Invites Shareholders to View and Listen to Webcast of April 23 Virtual 2026 Annual Meeting of Shareholders • Business Wire • 04/09/2026 02:00:00 PM
- Telix Strengthens Board with Additional Director Appointments • GlobeNewswire Inc. • 04/08/2026 10:44:20 PM
- AI-Enhanced Robotics in Pharma Manufacturing Signals Major Efficiency, Margin Expansion Opportunities • GlobeNewswire Inc. • 04/07/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 09:52:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 12:22:26 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 12:21:25 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 12:20:23 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 12:19:22 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 12:19:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 12:18:19 AM
- Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts • Business Wire • 03/24/2026 02:00:00 PM
- Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial • Business Wire • 03/23/2026 10:45:00 AM
- Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC • Business Wire • 03/20/2026 08:30:00 PM
- Pfizer’s TALZENNA combination shows progress against prostate cancer • IH Market News • 03/19/2026 02:44:13 PM
- TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer • Business Wire • 03/19/2026 10:45:00 AM
- Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer • Business Wire • 03/17/2026 10:45:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/16/2026 09:45:46 PM
